Michael S. Aberman, VP Strategy and Investor Relat at REGENERON PHARMACEUTICALS INC (REGN), sold 12,500 shares at $134.52 ($1.7M) on 2012-05-01, disclosed to the SEC on 2012-05-02.
Scheduled sale ($1.7M) by VP Strategy and Investor Relat under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.31 | 2,168 | $300K | 17.6% |
| 2 | $138.31 | 4,170 | $577K | 33.8% |
| 3 | $134.52 | 3,862 | $520K | 30.4% |
| 4 | $135.29 | 2,300 | $311K | 18.2% |
| Total | $136.58 avg | 12,500 | $1.7M | 100% |
| Filing → |
| REGN | SELL | 2015-03-19 | $1.6M | — | Filing → |
| REGN | SELL | 2015-02-25 | $1.4M | — | Filing → |
| REGN | SELL | 2015-02-18 | $1.5M | — | Filing → |